Related Experiment Videos
Genotyping of hepatitis C virus-comparison of three assays
Alexander C Haushofer1, Jörg Berg, René Hauer
1Institute of Laboratory Medicine, General Hospital St. Pölten, A-3100 St. Pölten, Austria. a.haushofer@kh-st-poelten.at
Insights
Accurate hepatitis C virus (HCV) genotyping is crucial for patient care. Three common assays demonstrated high reliability in identifying HCV genotypes and subtypes, supporting their use in routine diagnostics.
Area of Science:
- Clinical Virology
- Molecular Diagnostics
- Infectious Disease Epidemiology
Background:
- Hepatitis C virus (HCV) genotyping is essential for understanding disease spread, predicting patient outcomes, and guiding treatment strategies.
- Accurate identification of HCV genotypes and subtypes is critical for effective clinical management.
- The emergence of new therapies necessitates precise and reliable HCV genotyping methods.
Purpose of the Study:
- To evaluate and compare the accuracy and specificity of three distinct HCV genotyping assays.
- To determine the suitability of these assays for routine diagnostic laboratory use.
- To assess the performance of direct sequencing versus reversed hybridization methods for HCV subtyping.
Main Methods:
- A comparative analytical study was conducted using 100 clinical samples from patients with chronic hepatitis C.
- Three commercially available assays were evaluated: TruGene HCV 5'NC Genotyping Kit (direct sequencing), Inno-LiPA HCV II, and ViennaLab HCV Strip Assay (reversed hybridization).
- Amplification products from the Cobas Amplicor HCV Test served as the initial material for genotyping.
Main Results:
- The TruGene assay demonstrated high overall accuracy (97-100%) and specificity (97.7-100%) when compared to the other two assays.
- The Inno-LiPA HCV II and ViennaLab HCV Strip Assay also showed good performance, with accuracies ranging from 85.9% to 95.5% and specificities from 97% to 99.4%.
- All three assays effectively detected and differentiated common HCV genotypes and subtypes prevalent in Europe and North America.
Conclusions:
- The evaluated assays, including TruGene, Inno-LiPA HCV II, and ViennaLab HCV Strip Assay, are reliable for detecting and discriminating all common HCV genotypes.
- These methods are suitable for implementation in routine diagnostic laboratories for hepatitis C virus testing.
- The study confirms the clinical relevance of accurate HCV genotyping for patient management and epidemiological surveillance.
Background:
Genotyping of hepatitis C virus (HCV) is clinically relevant to epidemiology, prognosis, and therapeutical management of HCV infection.
Objectives:
Accuracy and specificity of three assays for HCV genotyping/subtyping were determined. The TruGene HCV 5'NC Genotyping Kit (TruGene), which is a direct sequencing test and two assays based on reversed hybridization, Inno-LiPA HCV II assay and ViennaLab HCV Strip Assay, were compared. Amplification products generated by the Cobas Amplicor HCV Test were used.
Study Design:
A total of 100 consecutive HCV RNA positive samples derived from patients with chronic hepatitis C were examined for their genotypes/subtypes by the three assays.
Results:
Identification of genotypes and subtypes by the TruGene assay as reference test for the Inno-LiPA HCV II assay and the ViennaLab HCV Strip Assay or Inno-LiPA HCV II assay as reference test for the TruGene and the ViennaLab HCV Strip Assay showed similar results for overall accuracies (TruGene as reference test for Inno-LiPA HCV II and ViennaLab HCV Strip Assay, genotypes/subtypes: 100%/95.5% and 97%/92%; Inno-LiPA HCV II as reference test for TruGene and ViennaLab HCV Strip Assay, genotypes/subtypes: 99%/85.9% and 97%/87.9%) and specificities (TruGene as reference test for Inno-LiPA HCV II and ViennaLab HCV Strip Assay, genotypes/subtypes: 100%/97.8% and 99%/97.7%; Inno-LiPA HCV II as reference test for TruGene and ViennaLab HCV Strip Assay, genotypes/subtypes: 100%/99.4% and 99.7%/98%).
Conclusions:
The three assays were found to be reliable for the detection and discrimination of all HCV genotypes common in Europe and in North America and to be suitable for the routine diagnostic laboratory.